Wayland, MA, United States of America

Jung-Ja Lee


Average Co-Inventor Count = 13.3

ph-index = 5

Forward Citations = 247(Granted Patents)


Company Filing History:


Years Active: 1998-2007

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations by Inventor Jung-Ja Lee

Introduction

Jung-Ja Lee is a distinguished inventor based in Wayland, MA, known for her significant contributions to the field of biotechnology. With a total of six patents to her name, Jung-Ja has focused her research on the modulation of amyloid peptide aggregation, which is crucial in addressing various amyloidogenic diseases.

Latest Patents

Her most recent patents revolve around compounds that modulate natural β-amyloid peptide aggregation. These innovative modulators primarily consist of peptides crafted entirely from D-amino acids. Specifically, Jung-Ja's inventions typically include peptides comprising 3–5 D-amino acid residues, featuring at least two residues from a selection that includes D-leucine, D-phenylalanine, and D-valine. A particularly noteworthy aspect of her work is the creation of retro-inverso isomers of β-amyloid peptides, which may be modified at either the amino-terminus, carboxy-terminus, or both. The patent also encompasses pharmaceutical compositions containing these compounds, alongside diagnostic and therapeutic methodologies aimed at treating amyloidogenic diseases.

Career Highlights

Jung-Ja Lee currently works with Praecis Pharmaceuticals, Inc., where she continues to advance her research and innovation efforts. Her patented inventions not only emphasize her expertise in biotechnology but also reflect her commitment to improving disease treatment options.

Collaborations

Throughout her career, Jung-Ja has collaborated with notable professionals in her field. Among her coworkers are Mark A. Findeis and Malcolm L. Gefter, who work alongside her to explore and develop cutting-edge therapeutic solutions.

Conclusion

Jung-Ja Lee’s work exemplifies the spirit of innovation in modern science, particularly in tackling complex health issues related to amyloid peptides. Her patents underscore her profound impact on the field, showcasing her role as a leading inventor in developing novel approaches to treat amyloidogenic diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…